ZCZC
BFF-52
HEALTH-VIRUS-BRITAIN-GERMANY-VACCINE
AstraZeneca says to boost vaccine manufacturing for Europe with Germany’s IDT Biologika
LONDON, Feb 10, 2021 (BSS/AFP) – Pharmaceutical group AstraZeneca announced on Wednesday that it will partner with Germany’s IDT Biologika to produce more Covid-19 vaccines for Europe.
The two companies are “exploring options” to accelerate output of the completed AstraZeneca vaccine in the second quarter of 2021, AstraZeneca said in a statement.
The agreement will see both companies invest to increase capacity at a production site in Germany to produce millions of doses per month by the end of 2022.
BSS/AFP/ARS/2052 hrs